Chezhiyan Sumithaa

Chezhiyan Sumithaa

Auto-generated profile, based on publicly available information

Chezhiyan Sumithaa

Department of Chemistry, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District 603 203, Tamil Nadu, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

5 July 2022 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
CSChezhiyan Sumithaa
Chezhiyan Sumithaa
TMTamilvelan Manjunathan
Tamilvelan Manjunathan
OMOlga Mazuryk
Olga Mazuryk
SPSilda Peters
Silda Peters
RPRenjith S. Pillai
Renjith S. Pillai
MGMani Ganeshpandian
Mani Ganeshpandian

20 October 2020 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
DGDurairaj Gopalakrishnan
Durairaj Gopalakrishnan
CSChezhiyan Sumithaa
Chezhiyan Sumithaa
Madan Kumar ArumugamMadan Kumar Arumugam
Madan Kumar Arumugam
NBNattamai S. P. Bhuvanesh
Nattamai S. P. Bhuvanesh
SGSuvankar Ghorai
Suvankar Ghorai
MGMani Ganeshpandian
Mani Ganeshpandian
A new organometallic ruthenium(II)–p-cymene complex bearing the antibacterial drug trimethoprim (RATMP(C)) has been synthesised, enwrapped into a polydiacetylene (PDA)-based liposome (Lip-RATMP(C)), and studied for its anticancer and antibacterial activities. The conjugated yne–ene chain of the polymeric backbone of PDA assists the formation of a stable nanoaggregate from which only 50% of the encapsulated complex was leached out even after 110 h under physiological conditions. RATMP(C) shows more efficient DNA cleavage activity than Lip-RATMP(C) and the DNA binding constant of the complex determined using UV-Visible absorption spectral titration illustrates the role of the hydrophobicity and hydrogen bonding propensity of the coordinated ligands in determining the DNA binding affinity of the complex. Cell viability assay reveals that the toxicity of RATMP(C) in healthy HEK-293 cells could be reduced when it is loaded into liposomes. Both RATMP(C) and Lip-RATMP(C) do not show marked cytotoxic activity against A549 human lung adenocarcinoma and MCF-7 human breast carcinoma cells. But, Lip-RATMP(C) exhibits cytotoxic activity and apoptosis-inducing ability against HepG2 human liver carcinoma cells with a potency higher than that of the complex, illustrating the significance of formation of the liposome–Ru(arene) complex nanoaggregate. In contrast, RATMP(C) showed potent antibacterial activity against Pseudomonas aeruginosa, and Staphylococcus aureus, whereas Lip-RATMP(C) turned out to be inactive even in the higher concentration tested.

6 December 2023 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
CSChezhiyan Sumithaa
Chezhiyan Sumithaa
PGPrzemysław Gajda-Morszewski
Przemysław Gajda-Morszewski
WIWickneswaran Ishaniya
Wickneswaran Ishaniya
TKThemmila Khamrang
Themmila Khamrang
MVMarappan Velusamy
Marappan Velusamy
MGMani Ganeshpandian
Mani Ganeshpandian
Despite the enormous efforts made over the past two decades to develop metallodrugs and nanocarriers for metallodrug delivery, there are still few precise strategies that aim to optimize the design of both metallodrugs and metallodrug carriers jointly in a concerted effort. In this work, three half-sandwich ruthenium(II) complexes with pyridylimidazo[1,5-a]pyridine ligand functionalized with polycyclic aromatic moiety (Ru(nap), Ru(ant), Ru(pyr)) are evaluated as possible anticancer candidates and polydiacetylene (PDA)-coated amino-functionalized mesoporous silica nanoparticles (AMSNs) are designed as a functional nanocarrier for drug delivery. Ru(pyr) exhibits higher cytotoxicity in HT-29 colorectal cancer cells compared to other complexes and cis-platin, but it does not exhibit better cellular uptake. Ru(pyr) is found to be preferentially accumulated in plasma, mitochondria, and ER-Golgi membrane. The complex induces cell cycle arrest in the G0/G1 phase, while higher concentrations cause programmed cell death via apoptosis. Ru(pyr) influences cancer cell adhesion property and acts as an antioxidant in HT-29 cells. In order to modulate the anticancer potency of Ru(pyr), AMSNs are used to encapsulate the complex, and then diacetylene self-assembly is allowed to deposit on the surface of the nanoparticles. Subsequently, the nanoparticles undergo topopolymerization, which results in π-conjugated PDA-Ru(pyr)@AMSNs. Owing to the ene-yne polymeric skeleton in the backbone, the non-fluorescent AMSNs turn into red-emissive particles, which are exploited for cell imaging applications. The release profile analysis reveals that such a π-conjugated polymer prevents the premature release of the complex from porous silica nanoparticles with the accelerated release of the complex in an acidic medium compared to physiological conditions. The PDA gatekeepers have also been proven to enhance the cellular internalization of Ru(pyr) with slow continuous release from the nanoformulation. Zebrafish embryo toxicity analysis suggests that the PDA-coated nanocarriers could be suitable candidates for in vivo investigations.

2 January 2024 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
WIWickneswaran Ishaniya
Wickneswaran Ishaniya
CSChezhiyan Sumithaa
Chezhiyan Sumithaa
MSMuthuraman Subramani
Muthuraman Subramani
AKAswathy Karanath-Anilkumar
Aswathy Karanath-Anilkumar
GMGanesh Munuswamy-Ramanujam
Ganesh Munuswamy-Ramanujam
MGMani Ganeshpandian
Mani Ganeshpandian
Polydiacetylene/lipid-coated silica nanorods for Ru(p-cymene)-piperlongumine complex delivery towards cancer cells.

14 August 2024 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
CSChezhiyan Sumithaa
Chezhiyan Sumithaa
KSKarnan Sugantharam
Karnan Sugantharam
AKAswathy Karanath-Anilkumar
Aswathy Karanath-Anilkumar
GMGanesh Munuswamy-Ramanujam
Ganesh Munuswamy-Ramanujam
MGMani Ganeshpandian
Mani Ganeshpandian
A self-reporting photo-responsive nanocarrier based on RAPTA-coordinated diacetylene acts as both a delivery vehicle and a real-time monitoring agent in vitro.